Drugs / 0.12% chlorhexidine solution
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT01446874 | Sep 2011 → Dec 2015 | esophageal cancer, lung neoplasm | Washington University School of Medicine | Terminated | No outcome recorded Stop: Enrollment |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 0.12% chlorhexidine solution | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01446874 ↗ |